-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The Injection Products Professional Committee of the Provincial Pharmaceutical Industry Association Established
Category:
Time：2018-11-08
On March 20, the inaugural founding conference of the Injection Preparations Professional Committee of the Hebei Province Pharmaceutical Industry Association, along with its first members’ congress, was held at the Ximei Wuzhou International Hotel. Our company, as the leading unit of the Injection Preparations Professional Committee, hosted this conference. This marks the second specialized committee officially established by the Provincial Pharmaceutical Industry Association. Attendees and speakers at the meeting included Wang Jinlong, Deputy Director of the Provincial Food and Drug Administration; Liu Xiaohan, Secretary of the Party Branch of the Provincial Pharmaceutical Industry Association; Zhang Baolin, Senior Vice President of the Hebei Province Pharmaceutical Industry Association; and Dr. Chen Zhen, a professor at Zhengzhou University and researcher at Yihong Business School, as well as representatives from 25 peer enterprises, including Shijiazhuang Fourth Pharmaceutical.
On March 20, the inaugural founding conference of the Injection Preparations Professional Committee of the Hebei Province Pharmaceutical Industry Association, along with its first members’ congress, was held at the Ximei Wuzhou International Hotel. Our company, as the leading unit of the Injection Preparations Professional Committee, hosted this conference. This marks the second professional committee officially established by the provincial pharmaceutical industry association.
Wang Jinlong, Deputy Director of the Provincial Food and Drug Administration; Liu Xiaohan, Secretary of the Party Branch of the Provincial Pharmaceutical Industry Association; Zhang Baolin, Senior Vice President of the Hebei Provincial Pharmaceutical Industry Association; and Dr. Chen Zhen, Professor at Zhengzhou University and Research Fellow at Yihong Business School—along with other relevant leaders and experts—attended the meeting and delivered speeches. Representatives from 25 peer companies, including Shijiazhuang Fourth Pharmaceutical, also participated in the meeting.
At the meeting, Yin Dianshu, Chief Engineer of the company and Director of the Institute of Pharmaceutical Research, who also serves as the Chairman of the Injection Products Professional Committee, delivered a speech. He stated that the establishment of the Injection Products Professional Committee has created a platform for the provincial pharmaceutical industry to facilitate technical exchanges, scientific and technological seminars, and expert consultations on injection products. This will further promote technological innovation and cooperation within the injection products sector, help member companies enhance their management capabilities in injection product production and operations, and drive the sustained and stable development of the province’s injection products industry.
At the meeting, the main tasks of the Injection Products Specialist Committee and its 2018 work plan were announced. The draft “Regulations on the Work of the Injection Products Specialist Committee” was reviewed and adopted. In addition, review experts from the Drug Review Center provided an interpretation of the latest policies regarding the consistency evaluation of chemical drug injections.
The meeting was chaired by Tian Pengmei, Secretary-General of the Injection Professional Committee of the Provincial Pharmaceutical Industry Association and Deputy Director of the Company’s Institute of Pharmaceutical Research.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license